Rifampin Tablets
150 · 300 · 450 · 600mg
Rifampicin tablets in four strengths from 150mg to 600mg, used for tuberculosis and meningococcal carriage. It blocks bacterial RNA polymerase.
From$0.39/ tabletView
Meningococcal Carriage
Meningococcal carriage refers to the presence of Neisseria meningitidis bacteria in the back of the throat without causing illness. Most carriers never develop disease, but they can transmit the bacterium to close contacts who may be more vulnerable. Carriage rates vary by age and setting, with young adults in shared living environments, including university halls and military barracks, showing higher colonisation rates.
Key points
- Most people who carry the bacterium in their throat stay well, though they can still pass it on to more vulnerable close contacts.
- Because rates of carriage differ by age and living situation, close-contact settings such as shared halls or barracks see higher colonisation.
- Antibiotics such as rifampicin are given only in specific situations, such as after a close contact develops invasive disease, and short full courses matter most.
Clearing the bacterium
Carriage itself rarely causes symptoms, so treatment is only recommended in specific situations, such as before or after a case of invasive meningococcal disease in a household or close contact. The goal is to eliminate the organism from the throat and prevent onward transmission.
Rifampicin is one of the established agents used for meningococcal carriage clearance, belonging to the broader class of antibiotics active against this pathogen. Short treatment courses are standard; full adherence matters because incomplete courses can allow the bacterium to persist.
If you or someone in your household has been identified as a close contact of a confirmed meningococcal case, seek medical assessment promptly.